跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOLSINT 112 MICROGRAMOS SOLUCION ORAL EN ENVASE UNIDOSIS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SOLSINT 112 MICROGRAMOS SOLUCION ORAL EN ENVASE UNIDOSIS
Approved
STANDARD
SOLSINT 112 MICROGRAMOS SOLUCION ORAL EN ENVASE UNIDOSIS
Ibsa Farmaceutici Italia S.R.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 16, 2021
Approval ID
4ab632d308eafb9e
Company
Ibsa Farmaceutici Italia S.R.L.
Type
Standard
Approval Details
Approval Id
4ab632d308eafb9e
Drug Cima Aemps Name
SOLSINT 112 MICROGRAMOS SOLUCION ORAL EN ENVASE UNIDOSIS
Register Number
85610
Holder Company Name
Ibsa Farmaceutici Italia S.R.L.
Marketing Company Name
Instituto Bioquimico Iberico Ibsa S.L.
Authorization Date
2021-02-16
Dosage Form
SOLUCIÓN ORAL EN ENVASE UNIDOSIS
Dose
112 microgramos
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
Yes
Company Name
Ibsa Farmaceutici Italia S.R.L.
Active Ingredients
LEVOTIROXINA SODICA
0,112 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 16, 2021
Approval ID
4ab632d308eafb9e
Type
Standard
Back to CIMA-AEMPS Approvals